Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,530 | -50,350 | -44,210 | -563,840 | -180,760 |
| Depreciation Amortization | 6,430 | 9,420 | 12,040 | 21,540 | 121,050 |
| Other Working Capital | -23,820 | -32,160 | -5,170 | 8,240 | 38,900 |
| Other Operating Activity | 14,370 | 4,700 | -30,370 | 439,180 | 40,090 |
| Operating Cash Flow | $-39,550 | $-68,390 | $-67,710 | $-94,880 | $19,280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,690 | -3,830 | -7,180 | -9,070 | -38,530 |
| Net Acquisitions | 0 | 0 | 0 | 0 | -14,840 |
| Other Investing Activity | 53,400 | -19,490 | 146,150 | -17,960 | -153,340 |
| Investing Cash Flow | $50,710 | $-23,320 | $138,970 | $-27,030 | $-206,710 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,550 | 3,660 | -53,880 | -124,200 | 502,040 |
| Financing Cash Flow | $1,550 | $3,660 | $-53,880 | $-124,200 | $502,040 |
| Exchange Rate Effect | 300 | 1,170 | -560 | -620 | 0 |
| Beginning Cash Position | 30,180 | 117,070 | 100,270 | 347,010 | 32,390 |
| End Cash Position | 43,210 | 30,180 | 117,070 | 100,270 | 347,010 |
| Net Cash Flow | $13,030 | $-86,890 | $16,800 | $-246,740 | $314,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,550 | -68,390 | -67,710 | -94,880 | 19,280 |
| Free Cash Flow | -39,550 | -68,390 | -67,710 | -94,880 | 19,280 |